Annual CFO
-$8.09 M
+$1.59 M+16.44%
June 30, 2024
Summary
- As of February 8, 2025, ANEB annual cash flow from operations is -$8.09 million, with the most recent change of +$1.59 million (+16.44%) on June 30, 2024.
- During the last 3 years, ANEB annual CFO has fallen by -$3.22 million (-66.09%).
- ANEB annual CFO is now -66.09% below its all-time high of -$4.87 million, reached on June 30, 2021.
Performance
ANEB Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$1.69 M
+$362.90 K+17.68%
September 30, 2024
Summary
- As of February 8, 2025, ANEB quarterly cash flow from operations is -$1.69 million, with the most recent change of +$362.90 thousand (+17.68%) on September 30, 2024.
- Over the past year, ANEB quarterly CFO has dropped by -$192.60 thousand (-12.86%).
- ANEB quarterly CFO is now -1151.85% below its all-time high of -$135.00 thousand, reached on September 30, 2020.
Performance
ANEB Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$7.05 M
+$1.04 M+12.81%
September 30, 2024
Summary
- As of February 8, 2025, ANEB TTM cash flow from operations is -$7.05 million, with the most recent change of +$1.04 million (+12.81%) on September 30, 2024.
- Over the past year, ANEB TTM CFO has increased by +$1.83 million (+20.63%).
- ANEB TTM CFO is now -5125.19% below its all-time high of -$135.00 thousand, reached on September 30, 2020.
Performance
ANEB TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ANEB Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.4% | -12.9% | +20.6% |
| 3 y3 years | -66.1% | -12.9% | +20.6% |
| 5 y5 years | - | -12.9% | +20.6% |
ANEB Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -66.1% | +16.4% | -41.0% | +40.7% | -29.7% | +32.0% |
| 5 y | 5-year | -66.1% | +16.4% | -1151.8% | +51.7% | -5125.2% | +32.0% |
| alltime | all time | -66.1% | +16.4% | -1151.8% | +51.7% | -5125.2% | +32.0% |
Anebulo Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.69 M(-17.7%) | -$7.05 M(-12.8%) |
| Jun 2024 | -$8.09 M(-16.4%) | -$2.05 M(+37.1%) | -$8.09 M(-9.0%) |
| Mar 2024 | - | -$1.50 M(-17.4%) | -$8.89 M(-7.2%) |
| Dec 2023 | - | -$1.81 M(-33.5%) | -$9.58 M(-7.7%) |
| Sep 2023 | - | -$2.73 M(-4.3%) | -$10.38 M(+7.2%) |
| Jun 2023 | -$9.68 M | -$2.85 M(+30.1%) | -$9.68 M(+9.6%) |
| Mar 2023 | - | -$2.19 M(-16.1%) | -$8.83 M(+9.0%) |
| Dec 2022 | - | -$2.61 M(+28.3%) | -$8.10 M(+21.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$2.03 M(+1.7%) | -$6.69 M(+23.1%) |
| Jun 2022 | -$5.44 M(+11.6%) | -$2.00 M(+36.8%) | -$5.44 M(-21.6%) |
| Mar 2022 | - | -$1.46 M(+21.9%) | -$6.94 M(+10.0%) |
| Dec 2021 | - | -$1.20 M(+54.1%) | -$6.30 M(+14.3%) |
| Sep 2021 | - | -$777.90 K(-77.8%) | -$5.51 M(+13.2%) |
| Jun 2021 | -$4.87 M | -$3.50 M(+321.9%) | -$4.87 M(+254.6%) |
| Mar 2021 | - | -$828.90 K(+102.2%) | -$1.37 M(+152.1%) |
| Dec 2020 | - | -$410.00 K(+203.7%) | -$545.00 K(+303.7%) |
| Sep 2020 | - | -$135.00 K | -$135.00 K |
FAQ
- What is Anebulo Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals annual CFO year-on-year change?
- What is Anebulo Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals quarterly CFO year-on-year change?
- What is Anebulo Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals TTM CFO year-on-year change?
What is Anebulo Pharmaceuticals annual cash flow from operations?
The current annual CFO of ANEB is -$8.09 M
What is the all time high annual CFO for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high annual cash flow from operations is -$4.87 M
What is Anebulo Pharmaceuticals annual CFO year-on-year change?
Over the past year, ANEB annual cash flow from operations has changed by +$1.59 M (+16.44%)
What is Anebulo Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of ANEB is -$1.69 M
What is the all time high quarterly CFO for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high quarterly cash flow from operations is -$135.00 K
What is Anebulo Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, ANEB quarterly cash flow from operations has changed by -$192.60 K (-12.86%)
What is Anebulo Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of ANEB is -$7.05 M
What is the all time high TTM CFO for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high TTM cash flow from operations is -$135.00 K
What is Anebulo Pharmaceuticals TTM CFO year-on-year change?
Over the past year, ANEB TTM cash flow from operations has changed by +$1.83 M (+20.63%)